Annual report pursuant to Section 13 and 15(d)

Consolidated Operations Statements

v3.21.2
Consolidated Operations Statements - USD ($)
12 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Income Statement [Abstract]    
Revenues $ 4,999,517 $ 403,940
Cost of goods sold 3,929,832 325,379
Gross Margin 1,069,685 78,561
Operating Expenses    
Operations 590,342
Research and development 516,084 488,990
Sales and marketing 172,182
General and administrative expenses 1,279,471 949,636
Stock based compensation 3,388,216 269,895
Total operating expenses 5,946,295 1,708,521
Operating loss (4,876,610) (1,629,960)
Other Expense (Income)    
Derivative expense 4,630,288
Change in fair value of derivative liability 2,492,894
Interest expense 1,223,767 29,186
Other, net 12,616 (57,215)
Other Expense (Income) 8,359,565 (28,029)
Net loss $ (13,236,175) $ (1,601,931)
Loss per share - basic and diluted $ (0.56) $ (0.12)
Weighted average shares outstanding - basic and diluted 23,655,743 13,732,205